What are Ardelyx's total assets?

Ardelyx (ARDX) holds $504.5M in total assets, up 23.0% year over year.

How much debt does Ardelyx have?

Ardelyx carries $208.3M in total debt against $148.6M of shareholders' equity, a debt-to-equity ratio of 1.40.

How much cash does Ardelyx have?

Ardelyx holds $31.2M in cash and equivalents.

Can Ardelyx cover its short-term obligations?

Its current ratio is 3.49 — current assets exceed current liabilities.

Where does Ardelyx's balance sheet data come from?

Every line is extracted from Ardelyx's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

Ardelyx ARDX Balance Sheet Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	TTM Q1 '26	TTM Q4 '25	TTM Q3 '25	TTM Q2 '25	TTM Q1 '25
Cash and cash equivalents	$31.21M+1.3%	$68M+4.7%	$42.72M-9.9%	$90.05M+115%	$30.81M-14.8%
Short-term investments	$206.87M+13.0%	$196.69M+6.2%	$199.99M+39.9%	$148.41M+3.0%	$183.14M+10.0%
Accounts receivable, net	$82.84M+78.3%	$71.85M+24.5%	$76.61M+44.0%	$62.55M+68.0%	$46.47M+65.0%
Inventories	$415.82M+40.7%	$392.64M+39.0%	$357.28M+43.2%	$326.87M+52.2%	$295.57M+59.5%
Raw materials	$27.94M-31.2%	$28.01M-9.0%	$27.62M+6.3%	$27.96M+7.9%	$40.61M+94.3%
Work in process	$90.04M+47.6%	$88.26M+50.4%	$92.96M+62.1%	$88.5M+60.5%	$60.99M+12.5%
Finished goods	$10.04M+135%	$6.84M+301%	$8.78M+379%	$6.81M+186%	$4.28M+14.1%
Prepaid expenses and other current assets	$23.58M+60.9%	$13.57M+22.3%	$15.45M+24.0%	$15.55M+38.0%	$14.65M+23.4%
Total current assets	$381.87M+22.1%	$382.32M+7.3%	$367.99M+29.5%	$351.57M+33.7%	$312.69M+21.2%
Property and equipment, net	$2M+20.2%	$2.18M+46.1%	$2.07M+101%	$2.14M+111%	$1.67M+63.4%
Accumulated depreciation	——	——	——	——	——
Operating lease right-of-use assets	5.6%-0.4%	5.6%-0.9%	5.6%-1.0%	5.6%-1.1%	6%-0.8%
Deferred tax assets	——	——	——	——	——
Other non-current assets	$6.68M-2.0%	$6.94M+28.1%	$6.78M+27.1%	$7.07M+29.6%	$6.82M+24.0%
Allowance for credit losses	——	——	——	——	——
Total assets	$504.51M+23.0%	$501.6M+15.1%	$486.17M+32.2%	$466.77M+35.9%	$410.19M+19.8%
Accounts payable	$28.2M+105%	$19.24M+20.2%	$18.39M+16.2%	$21.69M+99.3%	$13.72M-20.6%
Accrued expenses	$9.38M+30.9%	$19.11M+27.9%	$15.06M+30.5%	$11.81M+13.0%	$7.17M+6.6%
Deferred revenue	$3.25M-70.2%	$1.21M-88.7%	$6.58M-9.5%	$6.28M-42.0%	$10.91M+65.7%
Operating lease liabilities, current	$1.51M+16.0%	$1.48M-5.3%	$1.44M-44.1%	$1.18M-66.7%	$1.3M-69.8%
Contract liabilities	$13.7M+64.1%	$13.7M+89.4%	$13.7M+7.3%	$12.3M+27.9%	$8.35M-31.0%
Total current liabilities	$109.57M+44.5%	$88.61M+13.8%	$83.39M+18.3%	$81.72M+30.9%	$75.84M+33.3%
Deferred tax liabilities	——	——	——	——	——
Long-term debt	$203.52M+34.5%	$202.83M+34.5%	$202.14M+101%	$201.45M+101%	$151.3M+51.6%
Operating lease liabilities, non-current	$3.24M+29.2%	$3.64M+256%	$4.04M+232%	$4.02M+266%	$2.51M+222%
Operating Lease Liabilities (Total)	$4.75M+24.7%	$5.12M+98.1%	$5.47M+44.6%	$5.2M+11.9%	$3.81M-25.2%
Total liabilities	$355.89M+34.5%	$334.66M+27.5%	$331.89M+58.4%	$327.24M+66.5%	$264.52M+38.1%
Common stock	500M0.0%	500M0.0%	500M0.0%	500M0.0%	500M0.0%
Additional paid-in capital	$1.13B+5.7%	$1.11B+5.2%	$1.1B+5.0%	$1.09B+4.7%	$1.07B+4.7%
Retained earnings	-$984.54M-6.3%	-$946.94M-7.0%	-$946.53M-6.4%	-$945.56M-6.3%	-$926.48M-6.2%
Accumulated other comprehensive income (loss)	-$124K-789%	$198K+247%	$124K-33.0%	-$38K+62.4%	$18K+190%
Total stockholders' equity	$148.62M+2.0%	$166.95M-3.7%	$154.28M-2.5%	$139.53M-5.1%	$145.68M-3.5%
Total liabilities and stockholders' equity	$504.51M+23.0%	$501.6M+15.1%	$486.17M+32.2%	$466.77M+35.9%	$410.19M+19.8%
Available-for-Sale Debt Securities - Amortized Cost	$206.99M+13.0%	$196.49M+6.1%	$199.87M+40.0%	$148.45M+3.0%	$183.13M+10.0%
Available-for-Sale Debt Securities - Unrealized Loss Position (>=12 Months)	0—	0—	0—	0—	0—
Cash, Cash Equivalents, and Marketable Securities	$206.87M+13.0%	$196.69M+6.2%	$199.99M+39.9%	$148.41M+3.0%	$183.14M+10.0%
Available For Sale Securities Debt Securities Current	$206.87M+13.0%	$196.69M+6.2%	$199.99M+39.9%	$148.41M+3.0%	$183.14M+10.0%
Prepaid commercial manufacturing	$14.64M+5.7%	$14.48M-11.6%	$8.05M-51.7%	$12.74M-13.9%	$13.85M+151%
Deferred Tax Assets and Other Non-Current Assets	$6.68M-2.0%	$14.94M+84.0%	$6.78M+27.1%	$7.07M+29.6%	$6.82M+24.0%
Investments - Amortized Cost Basis	$206.99M+13.0%	$196.49M+6.1%	$199.87M+40.0%	$148.45M+3.0%	$183.13M+10.0%
Net Investment in Lease	$4.43M+20.8%	$4.8M+101%	$5.15M+42.1%	$5.01M+15.8%	$3.67M-20.9%
Investments and Cash	$238.07M+11.3%	$264.69M+5.8%	$242.71M+27.5%	$238.45M+28.2%	$213.95M+5.6%
Operating lease right-of-use assets	$4.43M+20.8%	$4.8M+101%	$5.15M+42.1%	$5.01M+15.8%	$3.67M-20.9%
Other non-current assets	$6.68M-2.0%	$6.94M+28.1%	$6.78M+27.1%	$7.07M+29.6%	$6.82M+24.0%
Prepaid commercial manufacturing, non-current	——	——	——	——	——
Property, plant and equipment at cost	——	——	——	——	——
Operating Lease Right-of-Use Assets in Other Assets	$4.43M+20.8%	$4.8M+101%	$5.15M+42.1%	$5.01M+15.8%	$3.67M-20.9%
Software and Technology Licenses, Net	$6.68M-2.0%	$6.94M+28.1%	$6.78M+27.1%	$7.07M+29.6%	$6.82M+24.0%
Tax Credit Carryforward Valuation Allowance	——	——	——	——	——
Accrued Manufacturing Costs	$9.38M+30.9%	$19.11M+27.9%	$15.06M+30.5%	$11.81M+13.0%	$7.17M+6.6%
Accrued Progress Collections and Price Adjustments	$13.7M+64.1%	$13.7M+89.4%	$13.7M+7.3%	$12.3M+27.9%	$8.35M-31.0%
Compensation and benefits	$9.38M+30.9%	$19.11M+27.9%	$15.06M+30.5%	$11.81M+13.0%	$7.17M+6.6%
Current portion of mortgage and loans payable	$0—	$0—	$0—	$0—	$0—
Other accrued liabilities	——	——	——	——	——
Lease Liability Payments - 2020 (Remaining Three Months)	——	——	——	——	——
Operating Lease Liability Payments - 2024 (Lessee)	$1.4M+34.4%	$1.84M+162%	$1.84M+162%	$1.69M+180%	$1.04M+217%
Operating Lease Liability Payments - 2025 (Lessee)	$1.4M+6,576%	$575K+364%	$575K+364%	$488K-19.2%	$21K-93.6%
Lease Liability Payments - Due Year Two	$1.4M+34.4%	$1.84M+162%	$1.84M+162%	$1.69M+180%	$1.04M+217%
Lease Liability Payments - Due Year Three	$575K+22.6%	$1.4M—	$1.4M—	$1.26M—	$469K—
Lease Liability Payments - Remainder of Fiscal Year	$1.84M+24.1%	$1.78M+7.5%	$1.78M+7.5%	$1.65M-1.0%	$1.48M+2.1%
Operating Lease Liability Payments Due	$5.16M+24.0%	$5.6M+104%	$6.02M+50.6%	$5.77M+18.4%	$4.16M-22.0%
Operating Lease Liability - Undiscounted Excess Amount	$408K+16.2%	$477K+198%	$551K+156%	$570K+153%	$351K+48.1%
Contract Liabilities, Non-Current	$13.7M+64.1%	$13.7M+89.4%	$13.7M+7.3%	$12.3M+27.9%	$8.35M-31.0%
Debt - Unamortized Discount (Premium) and Issuance Costs, Net	$1.03M-3.8%	$1.13M-0.8%	$1.23M+29.8%	$1.32M+26.1%	$1.07M-3.7%
Operating Lease Liability Payments - 2027 (Lessee)	$575K+22.6%	$1.4M—	$1.4M—	$1.26M—	$469K—
Accrued expenses and other liabilities	$67.23M+57.3%	$47.58M+37.3%	$41.93M+25.9%	$40.76M+52.6%	$42.74M+94.3%
Deferred revenue, net of current portion	$13.7M+64.1%	$13.7M+89.4%	$13.7M+7.3%	$12.3M+27.9%	$8.35M-31.0%
Total debt	$208.26M+34.3%	$207.95M+35.5%	$207.61M+98.7%	$206.64M+97.0%	$155.11M+47.8%
Unrecognized Tax Benefits	——	——	——	——	——
Common Stock Par Value Per Share	$0.000.0%	$0.000.0%	$0.000.0%	$0.000.0%	$0.000.0%
Common Stock Shares Issued	247M+3.2%	244.4M+2.7%	243M+2.6%	240.8M+2.3%	239.2M+2.2%
Common Stock Shares Outstanding	——	——	——	——	——
Additional paid-in capital	$1.13B+5.7%	$1.11B+5.2%	$1.1B+5.0%	$1.09B+4.7%	$1.07B+4.7%
Common stock; $0.001 par value; 6,000 shares authorized; 3,755 and 3,751 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively	$25K+4.2%	$24K0.0%	$24K0.0%	$24K+4.3%	$24K+4.3%
Number of Exercisable Options	17.7M+12.7%	18.1M+21.1%	17M+21.4%	16.3M+22.6%	15.7M+22.2%
Number of Vested and Expected to Vest Options	——	——	——	——	——
Share-Based Payment Award Options Outstanding - Number	29.8M-3.8%	29M+3.2%	30.1M+7.0%	29.8M+7.3%	31M+11.5%
Share Price	——	——	——	——	——
Unrealized Gains on Investments	$22K-60.7%	$201K+79.5%	$133K-31.1%	$11K+175%	$56K+24.4%
Unrealized Losses on Investments (Before Tax)	$146K+284%	$3K-94.5%	$9K+12.5%	$49K-53.3%	$38K-41.5%
Weighted Average Exercise Price of Outstanding Options	$5.69+2.2%	$5.54-1.6%	$5.52-0.9%	$5.51+1.7%	$5.57+5.3%
Weighted Average Exercise Price of Vested and Expected to Vest Options	——	——	——	——	——
Cumulative Cost Basis	$206.99M+13.0%	$196.49M+6.1%	$199.87M+40.0%	$148.45M+3.0%	$183.13M+10.0%
Accrued contract manufacturing expenses	——	——	——	——	——
Accrued gross to net revenue liabilities	——	——	——	——	——
Accrued medical affairs expenses	——	——	——	——	——
Accrued payments due to AstraZeneca	——	——	——	——	——
Accrued sales and marketing expenses	——	——	——	——	——
Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax	$146K+284%	$3K-94.5%	$9K+12.5%	$49K-53.3%	$38K-41.5%
Gross Unrealized Gains	$22K-60.7%	$201K+79.5%	$133K-31.1%	$11K+175%	$56K+24.4%
Total	$206.99M+13.0%	$196.49M+6.1%	$199.87M+40.0%	$148.45M+3.0%	$183.13M+10.0%
Available for sale investments	$206.87M+13.0%	$196.69M+6.2%	$199.99M+39.9%	$148.41M+3.0%	$183.14M+10.0%
Cash Cash Equivalents And Investments Gross Unrealized Losses	$146K+284%	$3K-94.5%	$9K+12.5%	$49K-53.3%	$38K-41.5%
Cash Cash Equivalents And Investments Gross Unrealized Gains	$22K-60.7%	$201K+79.5%	$133K-31.1%	$11K+175%	$56K+24.4%
Common stock, par value (in dollars per share)	$00.0%	$00.0%	$00.0%	$00.0%	$00.0%
Common stock, shares authorized (in shares)	$500M0.0%	$500M0.0%	$500M0.0%	$500M0.0%	$500M0.0%
Common stock, shares issued (in shares)	$246.97M+3.2%	$244.35M+2.7%	$242.97M+2.6%	$240.77M+2.3%	$239.2M+2.2%
Common Stock, Shares, Outstanding	$246.97M+3.2%	$244.35M+2.7%	$242.97M+2.6%	$240.77M+2.3%	$239.2M+2.2%
Contract With Customer, Gross To Net Sales Accruals	$53.43M+116%	$45.42M+66.5%	$43.19M+85.2%	$32.06M+81.4%	$24.79M+75.6%
Debt Instrument Fee Amount	$4.55M+91.7%	$3.96M+99.1%	$3.36M+1.9%	$2.77M-24.3%	$2.37M-40.8%
Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net	$1.03M-3.8%	$1.13M-0.8%	$1.23M+29.8%	$1.32M+26.1%	$1.07M-3.7%
Debt Securities, Available-for-Sale, Allowance for Credit Loss	——	——	——	——	——
Number of Securities, Greater than 12 months	$0—	$0—	$0—	$0—	$0—
Deferred Tax Liabilities, Gross	——	——	——	——	——
Deferred royalty obligation related to the sale of future royalties	$25.86M-2.5%	$25.88M+1.4%	$28.63M+17.5%	$27.76M+20.2%	$26.52M+21.2%
Amortization and depreciation	——	——	——	——	——
Deferred Tax Assets, Gross	——	——	——	——	——
Deferred Tax Assets, Net	——	——	——	——	——
Deferred Tax Assets, Net of Valuation Allowance	——	——	——	——	——
Deferred Tax Assets, Operating Loss Carryforwards	——	——	——	——	——
Deferred royalty obligation	——	——	——	——	——
R&D credit carryforward	——	——	——	——	——
Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-Based Compensation Cost	——	——	——	——	——
Deferred Tax Assets, Valuation Allowance	——	——	——	——	——
Deferred Tax Liabilities, Right Of Use Asset	——	——	——	——	——
Raw materials	$27.94M-31.2%	$28.01M-9.0%	$27.62M+6.3%	$27.96M+7.9%	$40.61M+94.3%
Investments And Cash, Amortized Cost	$238.2M+11.3%	$264.49M+5.8%	$242.58M+27.5%	$238.49M+28.2%	$213.93M+5.6%
Lessee Operating Lease Liability Payments Due	$5.16M+24.0%	$5.6M+104%	$6.02M+50.6%	$5.77M+18.4%	$4.16M-22.0%
Thereafter	——	——	——	——	——
Lessee Operating Lease Liability Undiscounted Excess Amount	$408K+16.2%	$477K+198%	$551K+156%	$570K+153%	$351K+48.1%
Number of options to extend	——	——	——	——	——
Total future payment obligation	$209.9M—	——	——	——	——
Loans Payable, Noncurrent	$203.52M+34.5%	$202.83M+34.5%	$202.14M+101%	$201.45M+101%	$151.3M+51.6%
Operating Lease Weighted Average Discount Rate Percent	$0.06-6.7%	$0.06-13.8%	$0.06-15.2%	$0.06-16.4%	$0.06-11.8%
Prepaid commercial manufacturing	$18.9M+10.5%	$14.5M-11.6%	$8.1M-51.5%	$12.7M—	$17.1M—
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price	——	——	——	——	——
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number	$17.72M+12.7%	$18.13M+21.1%	$17.04M+21.4%	$16.28M+22.6%	$15.72M+22.2%
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number	$29.81M-3.8%	$28.98M+3.2%	$30.14M+7.0%	$29.79M+7.3%	$30.99M+11.5%
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number	——	——	——	——	——
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value	——	——	——	——	——
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price	$5.69+2.2%	$5.54-1.6%	$5.52-0.9%	$5.51+1.7%	$5.57+5.3%
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value	——	——	——	——	——
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price	$5.31-2.6%	$5.43-1.6%	$5.42-1.3%	$5.41-0.4%	$5.45+3.0%
Share price (in dollars per share)	——	——	——	——	——
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value	——	——	——	——	——
Unrecognized tax benefits	——	——	——	——	——
Remainder of Fiscal Year 2024	——	——	——	——	——

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about Ardelyx.

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What are Ardelyx's total assets?: Ardelyx (ARDX) holds $504.5M in total assets, up 23.0% year over year.
How much debt does Ardelyx have?: Ardelyx carries $208.3M in total debt against $148.6M of shareholders' equity, a debt-to-equity ratio of 1.40.
How much cash does Ardelyx have?: Ardelyx holds $31.2M in cash and equivalents.
Can Ardelyx cover its short-term obligations?: Its current ratio is 3.49 — current assets exceed current liabilities.
Where does Ardelyx's balance sheet data come from?: Every line is extracted from Ardelyx's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.